An interesting issue is that MCT2 expression is associated with promising prognostic factors, namely the lack of metastases, low mitotic index and small tumour size, but surprisingly, MCT2 overexpression can be observed in lung cancer cells, the pancreas, prostate and colorectal [168]. This evidence concerns the gene SLC16A7 and neoplasm.